Skip to main content

Advertisement

SpringerLink
Log in

Multimodal Treatment for Lymph Node Recurrence of Esophageal Carcinoma After Curative Resection

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Although esophagectomy with extended lymph node dissection can improve survival of patients with esophageal carcinoma, lymph node metastasis has remained one of the main recurrence patterns. The aim of this study was to evaluate the outcome of intensive treatment for recurrent lymph node metastasis.

Methods

Recurrent lymph node metastasis was detected in 68 patients with thoracic esophageal carcinoma after curative esophagectomy (R0, International Union Against Cancer criteria). Multimodal treatment was performed in 41 patients: 19 patients underwent lymphadenectomy with adjuvant therapy, and 22 received definitive chemoradiotherapy and repeated chemotherapy. The remaining 27 patients (40%) received chemotherapy or best supportive care.

Results

Survival of the lymphadenectomy and the chemoradiotherapy groups was significantly better than that of the patients who received chemotherapy or best supportive care (P < .0001). Fifteen patients (79%) underwent curative lymph node dissection (R0) in the lymphadenectomy group. Complete response, partial response, and stable disease were obtained in 8 (37%), 10 (45%), and 4 (18%) patients who received chemoradiotherapy, respectively. There was no statistically significant difference in survival between the lymphadenectomy and the chemoradiotherapy groups. Although the location of lymph node metastasis did not influence survival significantly, seven patients with nodes around the abdominal aorta did not survive longer than 3 years. The most common repeat recurrence pattern was organ metastasis after the treatment. Multivariate analysis showed that the number of metastatic nodes and tumor marker were independent prognostic factors.

Conclusion

Multimodal treatment including lymphadenectomy and chemoradiotherapy could improve survival of the patients with lymph node recurrence of esophageal carcinoma after curative resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ide H, Nakamura T, Hayashi K, et al. Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 1994;18:321–30

    Article  PubMed  CAS  Google Scholar 

  2. Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225–32

    Article  PubMed  CAS  Google Scholar 

  3. Law SYK, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 1996;83:107–11

    Article  PubMed  CAS  Google Scholar 

  4. Nakagawa S, Kanda T, Kosugi S, et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004;198:205–11

    Article  PubMed  Google Scholar 

  5. Dresner SM, Griffin SM. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 2000;87:1426–33

    Article  PubMed  CAS  Google Scholar 

  6. Motoyama S, Kitamura M, Saito R, et al. Outcome and treatment strategy for mid- and lower- thoracic esophageal cancer recurring locally in the lymph nodes of the neck. World J Surg 2006;30:191–8

    Article  PubMed  Google Scholar 

  7. Yano M, Takachi K, Doki Y, et al. Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus 2006;19:73–7

    Article  PubMed  CAS  Google Scholar 

  8. Kato H, Miyazaki T, Nakajima M, et al. Value of positron emission tomography in the detection of recurrent oesophageal carcinomas. Br J Surg 2004;91:1004–9

    Article  PubMed  CAS  Google Scholar 

  9. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone respectable esophageal cancer. Am J Surg 2003;185:538–43

    Article  PubMed  Google Scholar 

  10. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005;23:2310–7

    Article  PubMed  Google Scholar 

  11. Nakamura T, Hayashi K, Ota M, et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004;188:261–6

    Article  PubMed  Google Scholar 

  12. Raoul JL, LePrise E, Julienne V, et al. Combined radiochemotherapy for postoperative recurrence of oesophageal cancer. Gut 1995;37:174–6

    Article  PubMed  CAS  Google Scholar 

  13. Nemoto K,Ariga H, Kakuto Y, et al. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Rad Oncol 2001;61:165–8

    Article  CAS  Google Scholar 

  14. Matsubara T, Ueda M, Takahashi T, et al. Localization of recurrent disease after extended lymph node dissection for carcinoma of the thoracic esophagus. J Am Coll Surg 1996;182:340–6

    PubMed  CAS  Google Scholar 

  15. Shimada H, Kitabayashi H, Nabeya Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24–31

    Article  PubMed  Google Scholar 

  16. Kato H, Fukuchi M, Miyazaki T, et al. Classification of recurrent esophageal cancer after radical esophagectomy with two- or three- field lymphadenectomy. Anticancer Res 2005;25:3461–8

    PubMed  Google Scholar 

  17. Japanese Society for Esophageal diseases. Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus. 9th ed. Tokyo: Kanehara & Co., 2001

    Google Scholar 

  18. Ishida K, Ando N, Yamamoto S, et al. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group Trial (JCOG9516). Jpn J Clin Oncol 2004;34:615–9

    Article  PubMed  Google Scholar 

  19. Sasamoto R, Sakai K, Inakoshi H, et al. Long-term results of chemoradiotherapy for locally advanced esophageal cancer, using daily low-dose 5-fluoraoufracil and cis-diamine-dichloro-platinum (CDDP). Int J Clin Oncol 2007;12:25–30

    Article  PubMed  CAS  Google Scholar 

  20. Nemoto K, Ariga H, Kakuto Y, et al. Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer. Am J Clin Oncol 2003;26:46–9

    Article  PubMed  CAS  Google Scholar 

  21. Nishimura Y, Koike R, Nakamatsu K, et al. Concurrent chemoradiotherapy with protracted infusion of 5-Fu and cisplatin for postoperative recurrent or residual esophageal cancer. Jpn J Clin Oncol 2003;33:341–5

    Article  PubMed  Google Scholar 

  22. Jingu K, Nemoto K, Matsushita H, et al. Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer 2006;6:50–9

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Tsutomu Nakamura MD, PhD, Masaho Ota MD, PhD, Kosuke Narumiya MD, PhD, Takuya Sato MD, Takeshi Ohki MD, PhD & Masakazu Yamamoto MD, PhD

  2. Department of Radiology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Norio Mitsuhashi MD, PhD

Authors
  1. Tsutomu Nakamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaho Ota MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kosuke Narumiya MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takuya Sato MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takeshi Ohki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masakazu Yamamoto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Norio Mitsuhashi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsutomu Nakamura MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, T., Ota, M., Narumiya, K. et al. Multimodal Treatment for Lymph Node Recurrence of Esophageal Carcinoma After Curative Resection. Ann Surg Oncol 15, 2451–2457 (2008). https://doi.org/10.1245/s10434-008-0016-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0016-x

Key words

Search

Navigation